BRIEF published on 06/19/2025 at 17:51, 5 months 15 days ago Key Scientific Presentations on Imeglimin at ADA 2025 Diabetes Therapeutic Potential Sumitomo Pharma Imeglimin Scientific Presentations
PRESS RELEASE published on 06/19/2025 at 17:46, 5 months 15 days ago Inside Information / Other news releases Poxel presents new Imeglimin data at ADA 2025 diabetes conference, highlighting therapeutic potential. Key presentations by Japanese experts Diabetes Therapeutic Potential Poxel Imeglimin ADA 2025
BRIEF published on 06/06/2025 at 19:10, 5 months 28 days ago Poxel: Details of share capital and voting rights Share Capital Voting Rights Actions Regulated Information Poxel
BRIEF published on 05/28/2025 at 07:35, 6 months 8 days ago TWYMEEG® Data Unveiled at Japan Diabetes Society Meeting Clinical Trials Diabetes Treatment TWYMEEG® Poxel SA Japan Diabetes Society
PRESS RELEASE published on 05/28/2025 at 07:30, 6 months 8 days ago Inside Information / Other news releases New clinical and scientific data on TWYMEEG® to be presented at the 68th Annual Meeting of the Japan Diabetes Society, showcasing efficacy, safety, and benefits in diverse patient groups Clinical Data Scientific Data TWYMEEG® Sumitomo Pharma Japan Diabetes Society
BRIEF published on 05/13/2025 at 07:35, 6 months 23 days ago Poxel's First Quarter 2025 Revenue and Business Developments Regulatory Approval Corporate Strategy Poxel Revenue TWYMEEG® Sales Royalties Increase
PRESS RELEASE published on 05/13/2025 at 07:30, 6 months 23 days ago Inside Information / Information on annual revenues Poxel reports consolidated revenue and corporate updates for Q1 2025, with TWYMEEG® sales growth in Japan and regulatory approval for diabetic patients with renal impairment Revenue Regulatory Approval Japan Poxel TWYMEEG
BRIEF published on 03/20/2025 at 21:50, 8 months 15 days ago Poxel Releases Positive Preclinical Results for HCM Treatment Preclinical Study Hypertrophic Cardiomyopathy PXL065 Myocardial Remodeling Cardiac Fibrosis
PRESS RELEASE published on 03/20/2025 at 21:45, 8 months 15 days ago Inside Information / Other news releases Poxel announces positive preclinical study results for PXL065, a potential treatment for Hypertrophic Cardiomyopathy, showing benefits in a mouse model Preclinical Study Poxel Hypertrophic Cardiomyopathy PXL065 Mouse Model
BRIEF published on 02/11/2025 at 20:33, 9 months 21 days ago Poxel Holds Combined General Meeting, Announces Key Results General Meeting Shareholder Voting Financial Delegations Remuneration Policy Poxel SA
Published on 12/05/2025 at 16:00, 30 minutes ago SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 45 minutes ago Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement
Published on 12/05/2025 at 15:35, 55 minutes ago XCF Global Moves to Double SAF Production with New Rise Reno Expansion
Published on 12/05/2025 at 15:00, 1 hour 30 minutes ago Calidi Biotherapeutics and Nova Minerals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Published on 12/05/2025 at 16:10, 20 minutes ago Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 29 minutes ago EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 29 minutes ago EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 16:00, 30 minutes ago Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025
Published on 12/05/2025 at 15:10, 1 hour 19 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 08:45, 7 hours 45 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 22 hours 30 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 22 hours 45 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 22 hours 46 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
